Drug Website, Directory & Medical Information

Desensitization feasible in patients with HSRs to chemotherapy 02 Sep 2025
Total dose desensitization is successful in patients with hypersensitivity reactions (HSRs) to chemotherapy, suggests a study.

Does aprepitant influence response to DICEP?

02 Sep 2025

Pembrolizumab prolongs real-world survival in NSCLC patients

01 Sep 2025

CYP3A5-guided tacrolimus dosing tied to faster achievement of target trough levels in kidney recipients

01 Sep 2025

Respiratory virus ups mortality risk in kids undergoing LT

01 Sep 2025

Flu infection tied to serious complications in children

31 Aug 2025

RSV infection a significant burden on children in Korea

30 Aug 2025

SGLT2 inhibitors lower stroke, mortality risks in AF patients with T2DM

29 Aug 2025

ADHD treatment helps prevent suicidal behaviours, accidents

29 Aug 2025

Adalimumab vs cyclosporine: Which is better for dermatological symptoms in VKH disease?

29 Aug 2025

Rituximab not superior to conventional therapy in EGPA

28 Aug 2025

Gender-neutral HPV vaccination – an important emerging need 21 Aug 2025;
The increasing incidence of human papillomavirus (HPV)–related diseases in males over recent years is turning the spotlight on gender-neutral vaccination (GNV) to prevent HPV-related diseases and cancers in both sexes. Professor Hung-Hsueh Chou from the National Tsing Hua University, Hsinchu, Taiwan, and Dr Mike Yat-Wah Kwan, President of the Asian Society for Pediatric Infectious Diseases (ASPID), and other experts in Hong Kong shared insights on the need for gender-neutral HPV vaccination, as well as possible ways to overcome vaccination barriers and bridge the gender gap.